Adriana Rocha Garcia, Ph.D., is passionate about helping people live healthier, fuller lives. As President and CEO of the Center for Health Empowerment in South Texas (CHEST), she works to expand healthcare access, reduce disparities and create opportunities for underserved communities. Help Adriana bring hope and healing to more families.
Every ripple begins with one person willing to take action. Champions are changemakers who share our mission, inspiring others to give and help save and improve lives.
About BioBridge Global
Mission: "To save and enhance lives through the healing power of human cells and tissue."
Since 1974, BioBridge Gobal has worked alongside the healthcare community to deliver lifesaving therapies and innovations in the development of advanced therapies through its family of nonprofits, including:
What begins as a single act of generosity gains momentum that can change lives across generations and advances the practice of medicine itself.
Funding BioBridge Global’s lifesaving mission helps turn bold ideas into medical innovations that can change the world.
Your support can help:
GROW THE BLOOD SUPPLY
Blood transfusions are the most common procedure in hospitals and South Texas Blood & Tissue (STB&T) plays a vital role in ensuring patients receive lifesaving care.
Blood donors are more critical than ever.
20% of Texas depends on blood from STB&T
1 in 7 patients will need a blood transfusion
15-20% growing need in blood is being driven by rapid population growth in South Texas
Your support can help STB&T build a permanent donor center in the Rio Grande Valley, giving more Texans an opportunity to save lives.
A larger donor base will strengthen our Heroes in Arms® pre-hospital blood supply, saving lives before patients reach the hospital.
Lyric
For Lyric and many living with sickle cell disease, blood transfusions are lifesaving, reducing pain and improving quality of life.
Cell and gene therapies begin with human cells donated by patients and healthy volunteers. These breakthroughs are transforming how cancer and auto-immune diseases are treated, but access remains limited:
Only 7 Texas Centers can deliver commercially available CAR T-Cell Therapies
Due to access barriers, Only 20% of CAR T-Cell Therapy eligible patients recieve treatment
Access to these therapies often depends on how far a patient can travel
In 2025, BBG Advanced Therapies launched the world's first mobile leukapheresis center, bringing critical cell collection to underserved communities and closing gaps in cancer care.
Simon
Inspired by his late father's fight with cancer, Simon has donated blood since 16 and in 2025 became the first stem cell donor in the mobile leukapheresis center.